Drug intelligence / Profile preview

prilocaine + bupivacaine

Development stage
Phase 4
Lead developer
Ain Shams University
Modality
Small Molecules
Administration
Intrathecal, Perineural
01

Overview

Prilocaine + bupivacaine is a combination anesthetic regimen being evaluated by **Ain Shams University** for the management of **postoperative pain** in patients undergoing ambulatory knee arthroscopy. This protocol, often referred to as "hybrid anesthesia," utilizes intrathecal hyperbaric prilocaine to provide rapid-onset, short-duration spinal anesthesia suitable for day-case surgery, combined with a peripheral nerve block (adductor canal block) using bupivacaine to provide extended postoperative analgesia. Both agents are amino-amide local anesthetics that function by inhibiting voltage-gated sodium channels on the neuronal membrane, thereby preventing the initiation and conduction of nerve impulses. The primary goal of this combination is to minimize the prolonged motor block typically associated with spinal bupivacaine while maintaining effective long-term pain control.

Other names
Hybrid Anesthesia (Prilocaine and Bupivacaine)intrathecal prilocaine and adductor canal block with bupivacaine
02

Targets

KATP channel (ATP-sensitive potassium channel)NMDAR (Glutamate receptor ionotropic, NMDA)PTGER1 (Prostaglandin E Receptor 1)CaV (Voltage-gated calcium channel protein complex)SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)SCN2A (Voltage-gated sodium channel protein type 2 subunit alpha)SCN9A (Sodium channel protein type 9 subunit alpha)

Beyond the preview

Go deeper on prilocaine + bupivacaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on prilocaine + bupivacaine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call